Actively Recruiting
Can Exercise Ameliorate Immunosenescence and Thereby Reduce Relapse in Head and Neck Cancer Patients
Led by Chang Gung Memorial Hospital · Updated on 2025-02-28
180
Participants Needed
1
Research Sites
234 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Through the implementation of this three-year project, investigators expect to find a safe and effective exercise prescription for patients with oral cancer after surgery. The findings will encourage and promise and add further support to the concept that exercise prescription is worth implementation as part of care for the patients with head and neck cancer.
CONDITIONS
Official Title
Can Exercise Ameliorate Immunosenescence and Thereby Reduce Relapse in Head and Neck Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 20 years or older
- Diagnosed with squamous cell carcinoma
- Scheduled to receive concurrent chemoradiotherapy (CCRT)
- Eastern Cooperative Oncology Group performance status less than 2
- Agree to blood draws, exercise training, and completing questionnaires
You will not qualify if you...
- Eastern Cooperative Oncology Group performance status 2 or higher
- Unable to tolerate basic exercise or concurrent chemoradiotherapy
- Mental illness or medical conditions that could worsen with exercise or are unmanageable
- Any medical condition unsuitable for exercise
- Refusal to participate in exercise, blood draws, or questionnaires
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
TuCheng Hospital
New Taipei City, Taiwan, 23652
Actively Recruiting
Research Team
W
Wan-Chin Kuo
CONTACT
K
Kuo
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here